## Mechanistic Overview
NAMPT-SIRT1 Axis as Master Regulator of SASP-Dependent Complement Amplification starts from the claim that modulating NAMPT, SIRT1 within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview NAMPT-SIRT1 Axis as Master Regulator of SASP-Dependent Complement Amplification starts from the claim that modulating NAMPT, SIRT1 within the disease context of neurodegeneration can redirect a disea
## Mechanistic Overview
Ketone-Based Metabolic Switching to Restore PV Interneuron Function starts from the claim that modulating SIRT3, PVALB within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Ketone-Based Metabolic Switching to Restore PV Interneuron Function starts from the claim that modulating SIRT3, PVALB within the disease context of neurodegeneration can redirect a disease-relevant process. The
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
5/11
dimensions won
NAMPT-SIRT1 Axis as Master Regulator of
7/11
dimensions won
Ketone-Based Metabolic Switching to Rest
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.70
0.65
Evidence
0.60
0.62
Novelty
0.75
0.72
Feasibility
0.65
0.78
Impact
0.68
0.70
Druggability
0.60
0.65
Safety
0.55
0.60
Competition
0.70
0.75
Data
0.80
0.72
Reproducible
0.65
0.60
KG Connect
0.08
0.08
Score Breakdown
Dimension
NAMPT-SIRT1 Axis as Master Reg
Ketone-Based Metabolic Switchi
Mechanistic
0.700
0.650
Evidence
0.600
0.620
Novelty
0.750
0.720
Feasibility
0.650
0.780
Impact
0.680
0.700
Druggability
0.600
0.650
Safety
0.550
0.600
Competition
0.700
0.750
Data
0.800
0.720
Reproducible
0.650
0.600
KG Connect
0.077
0.077
Evidence
NAMPT-SIRT1 Axis as Master Regulator of SASP-Dependent Compl
No evidence citations yet
Ketone-Based Metabolic Switching to Restore PV Interneuron F
No evidence citations yet
Debate Excerpts
NAMPT-SIRT1 Axis as Master Regulator of SASP-Depen
4 rounds · quality: 0.65
Persona-Theorist
# Novel Therapeutic Hypotheses for Neurodegeneration
## Hypothesis 1: ID2-Mediated PV Repression as a Convergence Point for Metabolic and Transcriptional Dysfunction
**Description:** Inhibitor of ...
Persona-Skeptic
1. **ID2-mediated PV repression**
- **Weaknesses:** The chain `AD -> ID2 up -> PV loss + PGC-1α suppression -> PV dysfunction` is mostly stitched from developmental or non-AD data, not direct adult AD...
Persona-Domain Expert
# Drug Development Feasibility Assessment: Neurodegeneration Hypotheses
## Executive Summary
Of the seven hypotheses, **PARP1** and **C3 complement pathway** have the clearest path to pharmacologi...
Persona-Synthesizer
```json
{
"ranked_hypotheses": [
{
"rank": 1,
"hypothesis_id": "H3_PARP1_NAD_depletion",
"hypothesis_name": "PARP1 Hyperactivation as NAD+-Depleting Driver of NAMPT Dysfuncti...
Ketone-Based Metabolic Switching to Restore PV Int
4 rounds · quality: 0.65
Persona-Theorist
# Novel Therapeutic Hypotheses for Neurodegeneration
## Hypothesis 1: ID2-Mediated PV Repression as a Convergence Point for Metabolic and Transcriptional Dysfunction
**Description:** Inhibitor of ...
Persona-Skeptic
1. **ID2-mediated PV repression**
- **Weaknesses:** The chain `AD -> ID2 up -> PV loss + PGC-1α suppression -> PV dysfunction` is mostly stitched from developmental or non-AD data, not direct adult AD...
Persona-Domain Expert
# Drug Development Feasibility Assessment: Neurodegeneration Hypotheses
## Executive Summary
Of the seven hypotheses, **PARP1** and **C3 complement pathway** have the clearest path to pharmacologi...
Persona-Synthesizer
```json
{
"ranked_hypotheses": [
{
"rank": 1,
"hypothesis_id": "H3_PARP1_NAD_depletion",
"hypothesis_name": "PARP1 Hyperactivation as NAD+-Depleting Driver of NAMPT Dysfuncti...